C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
6.45
+0.84 (14.97%)
At close: Nov 4, 2024, 4:00 PM
6.31
-0.14 (-2.17%)
After-hours: Nov 4, 2024, 7:38 PM EST
C4 Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -105.5 | -132.49 | -128.18 | -83.89 | -66.34 | -34.1 | Upgrade
|
| Depreciation & Amortization | 1.77 | 1.88 | 1.68 | 1.49 | 1.62 | 2.74 | Upgrade
|
| Other Amortization | - | 0.41 | 0.71 | 0.72 | 0.41 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.28 | -3.78 | 0.71 | 1.88 | -0.1 | 0.33 | Upgrade
|
| Stock-Based Compensation | 27.79 | 27.24 | 30.02 | 21.51 | 3.43 | 1.64 | Upgrade
|
| Other Operating Activities | 6.36 | 6.86 | 5.9 | 1.42 | 6.9 | - | Upgrade
|
| Change in Accounts Receivable | -9.84 | -10.33 | 4.24 | -1.23 | 0.14 | 81.82 | Upgrade
|
| Change in Accounts Payable | 0.23 | 0.27 | -3.33 | -1.18 | 0.47 | 4.23 | Upgrade
|
| Change in Unearned Revenue | 21.37 | 3.77 | -22.65 | -25.05 | -12.2 | -3.24 | Upgrade
|
| Change in Other Net Operating Assets | -8.13 | -0.66 | 4.96 | -2.63 | -1.58 | 2.17 | Upgrade
|
| Operating Cash Flow | -71.23 | -106.84 | -105.94 | -86.97 | -67.25 | 55.61 | Upgrade
|
| Capital Expenditures | -0.34 | -1.71 | -5.5 | -1.28 | -0.65 | -1.35 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.06 | Upgrade
|
| Investment in Securities | -32.65 | 160.06 | 63.92 | -188.06 | -189.86 | -0.33 | Upgrade
|
| Investing Cash Flow | -33 | 158.35 | 58.42 | -189.34 | -190.51 | -1.62 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 12.47 | - | Upgrade
|
| Long-Term Debt Repaid | - | -12.5 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -12.5 | - | - | 12.47 | - | Upgrade
|
| Issuance of Common Stock | 102.71 | 57.73 | 0.78 | 183.1 | 210.66 | 0.27 | Upgrade
|
| Repurchase of Common Stock | -0.19 | -0.11 | - | - | -0.92 | -0.03 | Upgrade
|
| Other Financing Activities | 0.38 | 0.37 | 0.37 | -11.7 | -23.31 | - | Upgrade
|
| Financing Cash Flow | 102.9 | 45.49 | 1.15 | 171.4 | 348.93 | 0.24 | Upgrade
|
| Net Cash Flow | -1.33 | 97 | -46.37 | -104.9 | 91.18 | 54.24 | Upgrade
|
| Free Cash Flow | -71.58 | -108.55 | -111.44 | -88.24 | -67.9 | 54.27 | Upgrade
|
| Free Cash Flow Margin | -212.59% | -522.96% | -358.36% | -192.73% | -204.55% | 253.80% | Upgrade
|
| Free Cash Flow Per Share | -1.11 | -2.19 | -2.28 | -1.92 | -5.97 | 39.55 | Upgrade
|
| Cash Interest Paid | - | 0.99 | 1.62 | 1.31 | 0.82 | - | Upgrade
|
| Cash Income Tax Paid | - | 1 | - | - | 0.14 | 1.09 | Upgrade
|
| Levered Free Cash Flow | -41.84 | -66.06 | -62.78 | -30.22 | -26.79 | 71.42 | Upgrade
|
| Unlevered Free Cash Flow | -41.84 | -65.6 | -62.11 | -29.59 | -26.43 | 71.42 | Upgrade
|
| Change in Net Working Capital | -2.01 | 6.12 | 7.35 | -0.01 | -6.95 | -90.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.